id	Preferred term	Synonymes	Source	Link	Function	Target	other ID		Term import ID	COVoc ID	Preferred label	Synonym	Narrow synonym	Broad synonym	Related synonym	x-refs	Comment
									ID	A cov:internal_covoc_id	A cov:preferred_covoc_label	A oboInOwl:hasExactSynonym SPLIT=||	A oboInOwl:hasNarrowSynonym SPLIT=||	A oboInOwl:hasBroadSynonym SPLIT=||	A oboInOwl:hasRelatedSynonym SPLIT=||	A oboInOwl:hasDbXref SPLIT=||	A rdfs:comment
CL_1	Caco-2		https://pubmed.ncbi.nlm.nih.gov/32149036/	https://web.expasy.org/cellosaurus/CVCL_0025	Successfully used to grow SARS-CoV-2		CLO:0002172		CLO:0002172	CL:1	Caco-2					PMID:32149036||CVCL:0025	Successfully used to grow SARS-CoV-2
CL_2	Calu-3		https://pubmed.ncbi.nlm.nih.gov/32165541/	https://web.expasy.org/cellosaurus/CVCL_0609	Successfully used to grow SARS-CoV-2		CLO:0002192		CLO:0002192	CL:2	Calu-3					PMID:32165541||CVCL:0609	Successfully used to grow SARS-CoV-2
CL_3	Calu-3 2B4		https://pubmed.ncbi.nlm.nih.gov/20090954/	https://web.expasy.org/cellosaurus/CVCL_YZ47	Successfully used to grow SARS-CoV-2				COVOC:0020001	CL:3	Calu-3 2B4					PMID:20090954||CVCL:YZ47	Successfully used to grow SARS-CoV-2
CL_4	HEK293T	293T 	https://www.biorxiv.org/content/10.1101/2020.03.02.972935v2	https://web.expasy.org/cellosaurus/CVCL_0063	Successfully used to grow SARS-CoV-2		EFO_0001184		EFO:0001184	CL:4	HEK293T	293T 				DOI:10.1101/2020.03.02.972935||CVCL:0063	Successfully used to grow SARS-CoV-2
CL_5	Huh-7		https://www.biorxiv.org/lookup/doi/10.1101/2020.03.02.972935 | https://pubmed.ncbi.nlm.nih.gov/31978945/	https://web.expasy.org/cellosaurus/CVCL_0336	Successfully used to grow SARS-CoV-2		EFO_0005384		EFO:0005384	CL:5	Huh-7					DOI:10.1101/2020.03.02.972935||PMID:31978945||CVCL:0036	Successfully used to grow SARS-CoV-2
CL_6	Vero		https://www.biorxiv.org/content/10.1101/2020.03.02.972935v2 | https://pubmed.ncbi.nlm.nih.gov/32165541/ | https://pubmed.ncbi.nlm.nih.gov/32149036/ | https://www.biorxiv.org/content/10.1101/2020.03.19.997890v1	https://web.expasy.org/cellosaurus/CVCL_0059	Successfully used to grow SARS-CoV-2		CLO:0009524		CLO:0009524	CL:6	Vero					DOI:10.1101/2020.03.02.972935v2||PMID:32165541||PMID:32149036||DOI:10.1101/2020.03.19.997890v1||CVCL:0059	Successfully used to grow SARS-CoV-2
CL_7	VeroE6	Vero C1008	https://www.biorxiv.org/content/10.1101/2020.03.02.972935v2 | https://pubmed.ncbi.nlm.nih.gov/32165541/ | https://pubmed.ncbi.nlm.nih.gov/32020029/ | https://pubmed.ncbi.nlm.nih.gov/31978945/ | https://www.biorxiv.org/content/10.1101/2020.03.07.982264v2 | https://pubmed.ncbi.nlm.nih.gov/32149036/	https://web.expasy.org/cellosaurus/CVCL_0574	Successfully used to grow SARS-CoV-2				COVOC:0020002	CL:7	VeroE6	Vero C1008				DOI:10.1101/2020.03.02.972935v2||PMID:32165541||PMID:32020029||PMID:31978945||DOI:10.1101/2020.03.07.982264v2||PMID:32149036||CVCL:0574	Successfully used to grow SARS-CoV-2
CL_8	VeroE6/TMPRSS2		https://pubmed.ncbi.nlm.nih.gov/32165541	https://web.expasy.org/cellosaurus/CVCL_YQ49	Successfully used to grow SARS-CoV-2				COVOC:0020003	CL:8	VeroE6/TMPRSS2					PMID:32165541||CVCL:YQ49	Successfully used to grow SARS-CoV-2
CL_9	CHO-K1		https://www.theage.com.au/national/coronavirus-outbreak-how-the-covid-19-vaccine-is-being-made-20200220-p542rh.html	https://web.expasy.org/cellosaurus/CVCL_0214	Cellular vaccines cell lines		CLO:0002462		CLO:0002462	CL:9	CHO-K1					https://www.theage.com.au/national/coronavirus-outbreak-how-the-covid-19-vaccine-is-being-made-20200220-p542rh.html||CVCL:0214	Cellular vaccines cell lines
CL_10	K-562		https://linkinghub.elsevier.com/retrieve/pii/S2590098620300130	https://web.expasy.org/cellosaurus/CVCL_0004	Cellular vaccines cell lines		CLO:0007059		CLO:0007059	CL:10	K-562					DOI:10.1016/j.medidd.2020.100026||CVCL:0004	Cellular vaccines cell lines
CL_11	PER.C6		https://www.jnj.com/coronavirus	https://web.expasy.org/cellosaurus/CVCL_G704	Cellular vaccines cell lines				COVOC:0020004	CL:11	PER.C6					https://www.jnj.com/coronavirus||CVCL:G704	Cellular vaccines cell lines
CL_12	47D11			NA	Hybridomas (prod. mAb against SARS-CoV)	against spike protein (S)			COVOC:0020005	CL:12	47D11						Hybridomas (prod. mAb against SARS-CoV)
CL_13	F26G1			NA	Hybridomas (prod. mAb against SARS-CoV)	against spike protein (S)			COVOC:0020006	CL:13	F26G1						Hybridomas (prod. mAb against SARS-CoV)
CL_14	F26G6			NA	Hybridomas (prod. mAb against SARS-CoV)	against spike protein (S)			COVOC:0020007	CL:14	F26G6						Hybridomas (prod. mAb against SARS-CoV)
CL_15	F26G8			NA	Hybridomas (prod. mAb against SARS-CoV)	against spike protein (S)			COVOC:0020008	CL:15	F26G8						Hybridomas (prod. mAb against SARS-CoV)
CL_16	F26G18			NA	Hybridomas (prod. mAb against SARS-CoV)	against spike protein (S)			COVOC:0020009	CL:16	F26G18						Hybridomas (prod. mAb against SARS-CoV)
CL_17	F26G19			NA	Hybridomas (prod. mAb against SARS-CoV)	against spike protein (S)			COVOC:0020010	CL:17	F26G19						Hybridomas (prod. mAb against SARS-CoV)
CL_18	N-176-15			CVCL_XA76	Hybridomas (prod. mAb against SARS-CoV)	against spike protein (S)			COVOC:0020011	CL:18	N-176-15					CVCL:XA76	Hybridomas (prod. mAb against SARS-CoV)
CL_19	S-9-11			CVCL_XA77	Hybridomas (prod. mAb against SARS-CoV)	against spike protein (S)			COVOC:0020012	CL:19	S-9-11					CVCL:XA77	Hybridomas (prod. mAb against SARS-CoV)
CL_20	rSN-18			CVCL_YQ10	Hybridomas (prod. mAb against SARS-CoV)	against nucleoprotein (N)			COVOC:0020013	CL:20	rSN-18					CVCL:YQ10	Hybridomas (prod. mAb against SARS-CoV)
CL_21	rSN-21-2			CVCL_YQ13	Hybridomas (prod. mAb against SARS-CoV)	against nucleoprotein (N)			COVOC:0020014	CL:21	rSN-21-2					CVCL:YQ13	Hybridomas (prod. mAb against SARS-CoV)
CL_22	rSN-29			CVCL_YQ14	Hybridomas (prod. mAb against SARS-CoV)	against nucleoprotein (N)			COVOC:0020015	CL:22	rSN-29					CVCL:YQ14	Hybridomas (prod. mAb against SARS-CoV)
CL_23	rSN-122			CVCL_YQ11	Hybridomas (prod. mAb against SARS-CoV)	against nucleoprotein (N)			COVOC:0020016	CL:23	rSN-122					CVCL:YQ11	Hybridomas (prod. mAb against SARS-CoV)
CL_24	rSN-150			CVCL_YQ12	Hybridomas (prod. mAb against SARS-CoV)	against nucleoprotein (N)			COVOC:0020017	CL:24	rSN-150					CVCL:YQ12	Hybridomas (prod. mAb against SARS-CoV)